Please click here to obtain permission to reproduce this image.

Click on image to view larger version.



Figure 6 (A) (Left) Risk stratification by C-reactive protein (CRP) (mg/dl) and rapid cardiac troponin T (cTnT) assay status expressed as 14-day mortality rate by CRP and rapid cTnT result. Early positive rapid cTnT assays are those that could be read positive by ≤10 min. Trend evaluated by chi-squared test. (Right) Mortality rate at 14 days by CRP and rapid cTnT assay status. Early positive rapid assays for cTnT are those for which the red line appeared by ≤10 min, with a "negative" test in this category including both negative and late positive rapid cTnT results. C-reactive protein ≥1.55 mg/dl is considered a positive test. "Test Positive" in the category "CRP ≥1.55 mg/dl and Rapid cTnT early positive" requires both tests to be positive, with a "negative" test in this category representing all other combinations. With permission from Morrow DA et al. J Am Coll Cardiol 1998;31:1460–5. (B) Incidence of death from cardiac causes at two years in the FRagmin during InStability in Coronary artery disease trial (FRISC) according to the presence or absence of ST-segment depression on the admission electrocardiogram and the maximal troponin T (TnT) levels during the first 24 h after enrollment and to the CRP levels and the maximal TnT levels. Neg = negative; Pos = positive. With permission from Lindahl B, et al. N Engl J Med 2000;343:1139–47.